Corporate Team
A Higher Brand of Management
Elite Clinical Network runs a tightly managed group of study sites that reflect the supervisory skills of a highly professional corporate team. Unlike the loose structure of an SMO, our organization relies upon hands-on attention to detail. Each management team member offers vast experience, research savvy and the skill to facilitate your studies in an efficient, expedient manner.
David S. Wilson

Chief Executive Officer
As Chief Executive Officer, David has launched and managed several successful clinical research sites over the course of his 18-year career. He has worked in every facet of the industry, including conducting phase one studies with many leading CROs and Sponsors. His goal has always been to create a network of clinical sites unlike a SMO that is able to achieve high enrollment while ensuring the highest quality data. "Our success is contributed to having a well-educated and diverse corporate team that is able to keep its finger on the pulse at all times, unlike a SMO we are a hands-on organization that knows how to achieve high enrollment while providing high quality data"
Dena Petersen, MD

Medical Director
After receiving a Bachelor’s degree in Electrical Engineering and working in the Engineering industry for several years, Dr. Petersen changed her career path and received a medical degree in 1977. She has sense been running her own successful solo practice in Tucson, Arizona and begin working in Clinical Research in 2001. She has conducted over 100+ clinical studies and her technical background has been contributed to numerous accolades and awards tied to high enrollment and high quality data.
Barry Heller, MD

Medical Director
As one of our designated Medical Directors, Dr. Heller is a certified Principal Investigator and lead director for the Emergency Department at Saint Mary’s Hospital and has over 30+ years of experience. He has conducted over 12 ABSSSI (skin infection) studies and has also contributed to over 150+ other clinical studies. He has made several presentations at many International Investigator meetings and has been a key asset in helping sponsors with protocol guidance and the creation of our in-depth and highly recognized SOPs (Standard Operating Procedures).